<DOC>
	<DOC>NCT01273012</DOC>
	<brief_summary>The purpose of this study is to determine whether the probiotic Infloran is cost-effective in treating acute childhood diarrhea.</brief_summary>
	<brief_title>Cost-effectiveness of Infloran (TM) in Treating Acute Childhood Diarrhea in Phramongkutklao Hospital</brief_title>
	<detailed_description>Probiotics have been proved to shorten duration of diarrhea in children; whether they are cost-effective is less clear. We'd like to validate the use of Infloran, a proprietary probiotic sold in Thailand, in terms of its cost-effectiveness compared to standard diarrhea care in our hospital setting.</detailed_description>
	<mesh_term>Diarrhea</mesh_term>
	<criteria>Children 3 months to 6 years of age Hospitalized due to acute diarrhea History of probiotic treatment in this episode of illness History of use of other antidiarrheal medications Chronic gastrointestinal disease(s) Severe dehydration Severe systemic disease(s)</criteria>
	<gender>All</gender>
	<minimum_age>3 Months</minimum_age>
	<maximum_age>6 Years</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>probiotic</keyword>
	<keyword>cost-effectiveness</keyword>
	<keyword>diarrhea</keyword>
	<keyword>children</keyword>
	<keyword>Sum of the monetary cost of the hospitalization</keyword>
</DOC>